94789-37-4

Basic information

• Product Name: 2-Pyrimidinecarbonitrile, 4-methoxy- (6CI,9CI)
• Synonyms: 2-Pyrimidinecarbonitrile, 4-methoxy- (6CI,9CI);4-MethoxypyriMidine-2-carbonitrile;2-Cyano-4-methoxypyrimidine
• CAS NO: 94789-37-4
• Molecular Formula: C6H5N3O
• Molecular Weight: 135.1234
• Product Categories: PYRIMIDINE
• Mol File: 94789-37-4.mol
• Article Data: 8

Chemical Properties

• Boiling Point: 294.0±32.0 °C(Predicted)
• Appearance: /
• Density: 1.24±0.1 g/cm3(Predicted)
• PKA: -1.74±0.20(Predicted)
• CAS DataBase Reference: 2-Pyrimidinecarbonitrile, 4-methoxy- (6CI,9CI)(CAS DataBase Reference)
• NIST Chemistry Reference: 2-Pyrimidinecarbonitrile, 4-methoxy- (6CI,9CI)(94789-37-4)
• EPA Substance Registry System: 2-Pyrimidinecarbonitrile, 4-methoxy- (6CI,9CI)(94789-37-4)

Safety Data

• Hazardous Substances Data: 94789-37-4(Hazardous Substances Data)

Usage

General Description

2-Pyrimidinecarbonitrile, 4-methoxy- (6CI,9CI) is a chemical compound with the formula C7H6N2O. It is a pyrimidine derivative that contains a cyano group and a methoxy group. This chemical is used in the pharmaceutical industry as an intermediate in the synthesis of various drugs and pharmacologically active compounds. It is also used in the production of agrochemicals, dyes, and other industrial chemicals. Additionally, 2-Pyrimidinecarbonitrile, 4-methoxy- (6CI,9CI) may have potential applications in research and development as a building block for the construction of novel compounds with therapeutic properties. Overall, this chemical plays a significant role in the synthesis of diverse compounds with important industrial and pharmaceutical applications.

Upstream product

• 7677-24-9 trimethylsilyl cyanide 
• 17758-55-3 4-Methoxypyrimidine 1-oxide 
• 557-21-1 zinc(II) cyanide 
• 22536-63-6 2-chloro-4-methoxypyrimidine 
• 557-21-1 dicyanozinc 

Relevant articles and documents

COMBINATION TREATMENTS COMPRISING ADMINISTRATION OF 1H-PYRAZOLO[4,3-B]PYRIDINES

The present invention provides 1H-pyrazolo[4,3-b]pyridin-7-amines of formula (I) as PDE1 inhibitors together with a second compound useful in the treatment of a neurodegenerative disorder and their combined use as a medicament, in particular for the treatment of neurodegenerative and/or cognitive disorders.

COMBINATION TREATMENTS COMPRISING ADMINISTRATION OF 1H-PYRAZOLO[4,3-B]PYRIDINES

The present invention provides 1H-pyrazolo[4,3-b]pyridin-7-amines of formula (I) as PDE1 inhibitors together with a second compound which compound is useful in the treatment of a psychiatric disorder and their combined use as a medicament, in particular for the treatment of psychiatric and/or cognitive disorders.

SUBSTITUTED PYRIDINES AND METHOD OF USE

The invention discloses compounds of Formula (I) wherein X, R1, R2, and R3 are as defined herein. The present invention relates to compounds and their use in the treatment of cystic fibrosis, methods for their production, pharmaceutical compositions comprising the same, and methods of treating cystic fibrosis by administering a compound of the invention.